DOVA

Dova Pharmaceuticals (DOVA)

Dova Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:DOVA

1 2 3 4 5 6 7 8 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2019/11/23	06:13	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/19	20:01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/18	20:02	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/13	06:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:44	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:35	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:33	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:32	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:30	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	23:19	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/12	20:07	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/02	06:03	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/11/02	06:01	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/18	00:23	PR Newswire (US)	Moore Kuehn, PLLC Encourages Milacron Holdings Corp. (MCRN), Ecology & Environmental, Inc. (EEI), Pivotal Software, Inc. (PVT...	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/12	06:16	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/12	06:09	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/05	07:12	PR Newswire (US)	SHAREHOLDER ALERT: WeissLaw LLP Investigates Dova Pharmaceuticals, Inc.	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/04	05:10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:DOVA	Dova Pharmaceuticals Inc
2019/10/04	05:09	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:DOVA	Dova Pharmaceuticals Inc